Vident Investment Advisory’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,045	Closed	-$331K	–	1235
2023 Q1	$331K	Buy	58,045 +2,821	+5%	+$17K	0.01%	920
2022 Q4	$557K	Buy	55,224 +20,274	+58%	+$381K	0.02%	671
2022 Q3	$723K	Sell	34,950 -812	-2%	-$23.5K	0.02%	681
2022 Q2	$886K	Buy	35,762 +13,540	+61%	+$374K	0.03%	661
2022 Q1	$862K	Buy	22,222 +3,716	+20%	+$144K	0.02%	750
2021 Q4	$1.08M	Buy	18,506 +2,023	+12%	+$115K	0.03%	673
2021 Q3	$977K	Sell	16,483 -1,178	-7%	-$92.4K	0.03%	686
2021 Q2	$1.53M	Buy	17,661 +841	+5%	+$67.8K	0.05%	510
2021 Q1	$1.39M	Sell	16,820 -69	-0.4%	-$6.61K	0.05%	516
2020 Q4	$1.54M	Sell	16,889 -24,781	-59%	-$1.54M	0.06%	393
2020 Q3	$1.67M	Sell	41,670 -2,910	-7%	-$102K	0.08%	301
2020 Q2	$1.53M	Sell	44,580 -32,314	-42%	-$963K	0.08%	305
2020 Q1	$1.71M	Sell	76,894 -4,801	-6%	-$121K	0.11%	217
2019 Q4	$1.6M	Buy	81,695 +1,274	+2%	+$20.2K	0.1%	319
2019 Q3	$1.25M	Sell	80,421 -2,298	-3%	-$44.1K	0.11%	141
2019 Q2	$1.68M	Sell	82,719 -13,596	-14%	-$245K	0.14%	101
2019 Q1	$1.69M	Sell	96,315 -3,479	-3%	-$54.9K	0.09%	316
2018 Q4	$1.28M	Sell	99,794 -94,906	-49%	-$1.32M	0.07%	367
2018 Q3	$3.17M	Sell	194,700 -12,976	-6%	-$153K	0.12%	215
2018 Q2	$2.35M	Buy	+207,676	New	+$2.29M	0.09%	296

Other funds holding FATE